Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 180

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

HLA-DQB1*0201: A Marker for Good Prognosis in British and Dutch Patients with Sarcoidosis

Sato, Hiroe, Grutters, Jan C., Pantelidis, Panagiotis, Mizzon, A. Neil, Ahmad, Tariq, van Houte, Arend-Jan, Lammers, Jan-Willem J., van den Bosch, Jules M.M., Welsh, Kenneth I., du Bois, Roland M. · 2002 · American Journal of Respiratory Cell and Molecular Biology

Abstract

Human leukocyte antigen (HLA)-DQB1 is one of the intriguing candidate genes in sarcoidosis. We performed high resolution molecular HLA-DQB1 typing on two groups of white patients (British [UK] and Dutch [NL]) in order to investigate the relationship between 19 DQB1 alleles and disease severity and progression. A total of 803 individuals were studied (133 UK and 102 NL patients, and 354 UK and 214 NL control subjects). Disease severity data included extrapulmonary disease, chest X-ray stage, lung diffusing capacity for carbon monoxide, and FVC. Progression was evaluated on follow-up chest radiographs (2 and 4 yr). The results showed DQB1*0201 to be strongly protective against severe sarcoidosis in both populations; in other words, it localized to Stage I at all time points (P < 0.0001, P(corrected) (P(c)) = 0.002), whereas another DQB1 allele, *0602, tended to have opposite effects. Further, a clear association was found between the *0201 allele and Löfgren's syndrome (P < 0.0001, P(c) = 0.001). More importantly, carriage of this allele reduced the risk of disease progression. In contrast, the other common split of DQB1*02, *0202, did not affect disease severity but was mildly protective against sarcoidosis in the UK population (P = 0.02, p(c) not significant). In conclusion, this study shows that DQB1*0201 is a strong marker for mild sarcoidosis. Additional mapping across the DQB1*0201-DRB1*0301 haplotype, including specific alleles at genes such as DRB3, tumor necrosis factor, lymphotoxin-alpha, I-kappa-B-like protein, and B-associated transcript 1, is necessary for a final localization of the protective effect on this haplotype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1165/rcmb.4782

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 180

Metadata

Authors
Sato, H., Grutters, J. C., Pantelidis, P., Mizzon, A. N., Ahmad, T., van Houte, A.-J., Lammers, J.-W. J., van den Bosch, J. M. M., Welsh, K. I., & du Bois, R. M.
Venue
American Journal of Respiratory Cell and Molecular Biology
Published
2002-10
Volume
27
Issue
4
Pages
406-412
ISSN
  • 1044-1549 (ISSN-L)
  • 1535-4989
OpenAlex
W1846492962
Cited by
180
References
1
FWCI
6.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HLA-DQB1*0201: A Marker for Good Prognosis in British and Dutch Patients with Sarcoidosis. https://app.cochat.ai/papers/10.1165/rcmb.4782
The paper
Sato, H., Grutters, J. C., Pantelidis, P., Mizzon, A. N., Ahmad, T., van Houte, A.-J., Lammers, J.-W. J., van den Bosch, J. M. M., Welsh, K. I., & du Bois, R. M. (2002). HLA-DQB1*0201: A Marker for Good Prognosis in British and Dutch Patients with Sarcoidosis. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.4782

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.